With new research and commercial test launches, clincians anticipate exciting new tools but judging quality and utility has become challenging.
The selective whole-genome amplification approach was successfully adapted to Plasmodium vivax, a parasite that is notoriously difficult to culture.
The study seeks to identify biomarkers that can help personalize treatment for patients by identifying signs of rapid decline in kidney function.
Peter Nowell, one of the discoverers of the Philadelphia chromosome, has died.
University of Pennsylvania researchers found that patients with autism had a greater mutational burden in essential genes than their unaffected siblings.
The study, which is still ongoing, also provided support for a separate Phase 2/3 trial of a targeted treatment for the neurodevelopmental disorder.
The large-scale study is designed to advance personalized medicine for pancreatic cancer to help meet the organization's goal of doubling patient survival rates by 2020.
Clinicians and genetic counselors are coming up with triage strategies for cancer cases in which medically actionable germline mutations are suspected.
The device, which will be tested in collaboration with a Panamanian research institute, will run 40-minute tests without the need for electricity.
UPenn will establish the Coordinating Center for Genetics and Genomics of Alzheimer's Disease in collaboration with five other institutions.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.
Some science companies will be taking part in next month's March for Science, Fortune reports.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.